Corvus Pharmaceuticals, Inc. (CRVS) Earnings
NASDAQ·Healthcare·Biotechnology
$11.93
+3.92%
Mkt Cap $1.00B
EPS — Estimate vs Actual
Mkt Cap
$1.00B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.55
NASDAQ·Healthcare·Biotechnology
$11.93
+3.92%
Mkt Cap $1.00B
Mkt Cap
$1.00B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.55